Memorandum of Understanding with Royal College of Podiatry Memorandum of Understanding with Royal College of Podiatry 12 November 2024 The MOU between the RCP and BOFAS is a landmark document outlining similarities and differences between the two professional groups. This is pertinent to all surgeons and patients. Click for more details. Read more
Australian Orthopaedic F&A Society Australian Orthopaedic F&A Society Seeking Expressions of Interest for August 2026 11 November 2024 The Australian Orthopaedic Foot & Ankle Society is seeking expressions of interest from BOFAS Members interested in joining their 2026 annual meeting in Singapore. Read more
BOFAS EDI 'Alternative Pathways Session' BOFAS EDI 'Alternative Pathways Session' Wednesday 6th November 2024 @ 20.00 GMT 29 September 2024 Click the link to register for free for an informal and informative session covering career progression for SAS and LED doctors (Zoom). Read more
2Oct2025 BOFAS Principles Course - Dubai 02/10/2025 - 04/10/2025 Read more The aim is to give Overseas Trainee Orthopaedic Surgeons a solid grounding in the principles and the decision making in Foot & Ankle Surgery. There is an emphasis on clinical examination of cases, small group discussions and learning surgical approaches in the cadaver lab. This is the first course BOFAS is running in UAE and the aim is to expand the Foot and Ankle education and training in the Middle East and Gulf area. Venue - Le Meridien, Dubai, United Arab Emirates Documents to download ACv3BOFAS-Principles-Course-Programme-DXB(.pdf, 2.13 MB) - 569 download(s) Read more
20Oct2025 BOFAS Principles Course Taunton 20/10/2025 - 21/10/2025 Read more These courses are aimed at Higher Surgical Trainees / ST3 onwards and are designed to teach the core of Foot and Ankle surgery in an informal and interactive environment. The emphasis is on clinical examination cases, discussion groups and typical day-to-day clinic scenarios. Although not an exam preparation course, content is taught to the standard expected in the FRCS(Tr & Orth) exam; that of a day-one non-specialist orthopaedic consultant. Applications will open on 1st September 2023. Venue - Taunton (TBC) Documents to download BOFAS-Course-Programme--Taunton-2025(.docx, 31.88 KB) - 785 download(s) Read more
Togay Koç / 27 June 2022 / Categories: Abstracts, 2013, Poster The interim results on estimation of a forefoot surgery quality-adjusted life years (QALY)? R. Ahluwalia, N. Blucher, H. Kielghty, P. Weller, S. Platt, M. Hennessy Introduction: Planned reduction in expenditure can be expected to result in rationing of NHS services. A method of assessing the financial benefit of a treatment is to estimate the quality-adjusted life years (QALY’s). The aim of this study was to perform a cost-utility analysis of forefoot surgery. Methods: During a period between October 2011 and March 2012 all forefoot procedures were prospectively followed with the MOXFQ up to 1- year. We followed the health economic analysis as identified by Jenkins et al 2013. Health states derived from the MOXFQ were converted to a single summary index on a scale of -1 to 1, where 1 represents perfect health, and 0 represents no change. Using life expectancy tables we calculated the time spent in that state (in years) to derive the QALY’s gained or lost. Surgical costs were identified as per the HRG code to calculate the cost per QALY. Statistical analysis was undertaken to test the normality of data and 95% confidence intervals. Results: 36 patients, with an average-age of 63.4yrs underwent forefoot surgery between Oct 2012- March 2012. All patients had hallux valgus correction with correction of lesser toe deformities and completed pre-operative MOXFQ and post-operative 1 year MOXFQ. We found a 33.4% (29.4-36.7%) positive improvement in MOXFQ at 1- year and identified the mean QALY gained is 4.9, as the average age at death on the Wirral 78.2 meaning any foot health improvement could potentially last 14.8 yrs. Our coding department identified the mean cost of surgery, was £3082.42 in this group and the mean lifetime cost-per-QALY is £733.90 if patient health remained static. Conclusion: Forefoot surgery appears a cost-effective and compares favourably with both THR and TKR. We advocate further study into the QALY value for specific forefoot procedures and variance due to yearly change in NHS-payment structures. Print 566 Tags: Outcome Measures